Literature DB >> 2455265

Transforming activity of ras proteins translocated to the plasma membrane by a myristoylation sequence from the src gene product.

P M Lacal1, C Y Pennington, J C Lacal.   

Abstract

Ras p21 proteins exert their biological functions when associated to the inner surface of the plasma membrane. This association is mediated by a lipid molecule which is covalently attached to the protein by a thioester bond through a cysteine at residue 186, at the carboxy end of the molecule. Deletion or substitution of the critical Cys186 residue of the Harvey-ras protein leads to ras-p21 mutants lacking the ability to translocate to the membrane and devoid of transforming activity (Willumsen et al., 1984a, 1984b). We have been able to regenerate both localization to the plasma membrane as well as transforming activity of such mutant ras p21 proteins by fusion of the amino-terminal 15 residues of the v-p60src protein, responsible for the covalent binding of myristic acid and its membrane association. Thus, while translocation to the plasma membrane is necessary for function of the transforming Harvey-ras p21 protein, it appears to be independent of a specific membrane insertion mechanism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455265

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  The structure of the carboxyl terminus of the p21 protein. Structural relationship to the nucleotide-binding/transforming regions of the protein.

Authors:  P W Brandt-Rauf; R P Carty; J M Chen; G Lee; S Rackovsky; M R Pincus
Journal:  J Protein Chem       Date:  1990-04

2.  A myristylated form of the sea oncoprotein can transform chicken embryo fibroblasts.

Authors:  A J Crowe; M J Hayman
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

Review 3.  Acylation of viral and eukaryotic proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

4.  The amino-terminal 14 amino acids of v-src can functionally replace the extracellular and transmembrane domains of v-erbB.

Authors:  M McMahon; R C Schatzman; J M Bishop
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

5.  Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src.

Authors:  J W Wills; R C Craven; R A Weldon; T D Nelle; C R Erdie
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

6.  Diacylglycerol production in Xenopus laevis oocytes after microinjection of p21ras proteins is a consequence of activation of phosphatidylcholine metabolism.

Authors:  J C Lacal
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

7.  Polylysine domain of K-ras 4B protein is crucial for malignant transformation.

Authors:  J H Jackson; J W Li; J E Buss; C J Der; C G Cochrane
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Cationic modulation of rho 1-type gamma-aminobutyrate receptors expressed in Xenopus oocytes.

Authors:  D J Calvo; A E Vazquez; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release.

Authors:  R A Weldon; J W Wills
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity.

Authors:  P F Lebowitz; J P Davide; G C Prendergast
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.